1. Using patient DNA to optimize therapy in heart failure patients: a move toward perfection

   • Howard L. McLeod

   OriginalPaper 04 July 2009 Pages: 183 - 185

2. β-Blocker pharmacogenetics in heart failure

   • Jaekyu Shin
   • Julie A. Johnson

   OriginalPaper 24 April 2008 Pages: 187 - 196

3. PPAR transcriptional activator complex polymorphisms and the promise of individualized therapy for heart failure

   • Neville F. Mistry
   • Sharon Cresci

   OriginalPaper 08 November 2008 Pages: 197 - 207

   

4. Renin–angiotensin–aldosterone system (RAAS) pharmacogenomics: implications in heart failure management

   • Amber L. Beitelshees
   • Issam Zineh

   OriginalPaper 20 March 2008 Pages: 209 - 217

   

5. Genetic variation in the natriuretic peptide system and heart failure

   • David E. Lanfear

   OriginalPaper 11 October 2008 Pages: 219 - 228

   

6. Genomics, heart failure and sudden cardiac death

   • Dawood Darbar

   OriginalPaper 24 April 2008 Pages: 229 - 238

   

7. Understanding the pharmacogenetic approach to warfarin dosing

   • Ingrid Glurich
   • James K. Burmester
   • Michael D. Caldwell

   OriginalPaper 08 November 2008 Pages: 239 - 248